Dr. Kubota founded Acucela in 2002. He spent his early career performing ocular research at Keio University, where he earned his MD and PhD. In the course of his work there, he discovered a glaucoma gene, myocilin, earning him the Suda Award. Dr. Kubota practiced ophthalmology in Japan and was assistant professor, University of Washington.
Dr. Kubota is a member of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Japanese Ophthalmological Society, Keio Medical Society, and is on Japan-America Society, State of Washington Board. He was named one of Seattle Business Magazine’s Top 25 Innovators & Entrepreneurs; and one of the most inspiring people in the life sciences industry by PharmaVOICE and was selected as one of the Nikkei Business 100, Nikkei Business Magazine’s inaugural list of the most influential people to Japan’s future. He was selected as an Emerging Pharmaceutical Industry Leader by Pharmaceutical Executive. He was profiled in AERA Magazine and was named Emerging Leader - Japan, a US/Japan Innovation Award, Japan Society of Northern California and Stanford University’s US-Asia Technology Management Center.